As capital sources become more elusive, companies are increasingly exploring creative methods to structure transactions and it is more important than ever to find successful transaction structures that build value. This session will focus on unique financial structures that have been utilized to leverage industry and financing opportunities.
This panel will review the following:
Combined deferred mergers and product development licenses
Debt transactions
Equity lines
The use of business incubators
Moderator:
- Richard A. Kaufman, Partner, Foley & Lardner
Panelists:
- Mark Benedyk, Head of The Pfizer Incubator LLC
- Donna Tempel, Ph.D., President and CEO, Drais Pharmaceuticals
- Jack Lief, Co-Founder, Chairman, President & CEO, Arena Pharmaceuticals
- Michael White, Deal Team Leader, Silicon Valley Bank
Related Insights
09 October 2024
Energy Current
Mexican Administration Offers Boost to Clean Energy, Infrastructure Under New Leadership
Claudia Sheinbaum made history last week as Mexico’s first female president and laid out her vision to promote clean energy and increase investment in the infrastructure sector.
09 October 2024
Legal News: International Trade Enforcement & Compliance
Five Compliance Best Practices for … Internal Controls and SOPs
Drafting effective internal controls and standard operating procedures is essential for ensuring consistency, efficiency, and compliance with organizational policies and regulatory requirements.
09 October 2024
Manufacturing Industry Advisor
What Every Multinational Company Should Know about … Conducting International Internal Investigations
Conducting effective cross-border internal investigations is more critical than ever for companies facing increasingly complex regulatory frameworks across the globe.